Xlife Sciences AG (XSWX:XLS) Total Stockholders Equity : CHF305.26 Mil (As of Dec. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Xlife Sciences AG Total Stockholders Equity?

Xlife Sciences AG's Total Stockholders Equity for the quarter that ended in Dec. 2024 was CHF305.26 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Xlife Sciences AG's Book Value per Share for the quarter that ended in Dec. 2024 was CHF53.16. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Xlife Sciences AG's Debt-to-Equity for the quarter that ended in Dec. 2024 was 0.19.

Xlife Sciences AG Total Stockholders Equity Historical Data

The historical data trend for Xlife Sciences AG's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xlife Sciences AG Total Stockholders Equity Chart

Xlife Sciences AG Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Stockholders Equity

Get a 7-Day Free Trial

130.17

211.23

235.23

268.17

305.26

Xlife Sciences AG Semi-Annual Data
	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Total Stockholders Equity	Get a 7-Day Free Trial								235.23	232.85	268.17	272.83	305.26

Xlife Sciences AG (XSWX:XLS) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Xlife Sciences AG's Book Value per Share for the quarter that ended in Dec. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(305.26	-	0)	/	5.742
	=	53.16

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Xlife Sciences AG's Debt-to-Equity for the quarter that ended in Dec. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(5.358	+	53.89)	/	305.26
	=	0.19

Xlife Sciences AG Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Xlife Sciences AG's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Xlife Sciences AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Xlife Sciences AG (XSWX:XLS) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

XLSz:UK

Address

Talacker 35, Zurich, CHE, 8001

Website

https://www.xlifesciences.ch

Xlife Sciences AG is a Swiss incubator and accelerator company focused on the value development and commercialization of research projects from universities and other life science research institutions, to provide solutions for high unmet medical needs. It holds majority or minority interests in project companies that are engaged in areas of the company's reportable segments which include Technology platforms, Medical Technology, Biotechnology/Therapeutics, and Artificial intelligence/digital medicine.

Xlife Sciences AG Headlines

No Headlines